Condition: Prodromal Parkinsons Disease · Sponsor: Michael J. Fox Foundation for Parkinson's Research
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The study is a longitudinal, multi-center study to assess progression of \[18F\] AV-133 imaging in Prodromal PD participants. Participants will be followed for up to 24 months. Approximately 100 Prodromal participants will be recruited from up to 10 sites. Participants will be comprehensively assessed at baseline and follow up. Participants will undergo imaging assessments with \[18F\] AV-133 and clinical (motor, neuropsychiatric, cognitive and imaging and biomarker) assessments (conducted under the PPMI Clinical protocol).
This description comes directly from the study's public registry record.
Lianne Ramia · 203-590-5600 · LRamia1@indd.org
Jessica Dimos · 203-590-5600 · jdimos@indd.org
Always discuss trial participation with your own doctor first.
| Institute for Neurodegenerative Disorders | New Haven, Connecticut, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| Toronto Western Hospital | Toronto, Ontario, Canada | Not Yet Recruiting |
| Philipps-University of Marburg | Hessen, Germany | Not Yet Recruiting |
| Tel Aviv Sourasky Medical Center | Tel Aviv, Israel | Not Yet Recruiting |
| Radboud University | Nijmegen, Gelderland, Netherlands | Not Yet Recruiting |
| Queen Mary University of London | London, Britain, United Kingdom | Recruiting |
| Newcastle University | Newcastle upon Tyne, Tyne and Wear, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.